This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
3 Sector ETFs & Stocks That Survived October Upheaval
by Sweta Killa
A few sectors easily survived the market rout and traded in the green last month. We have highlighted such three sectors and their best ETFs & stocks that have gained handsomely in October.
Boston Beer (SAM) Beats on Q3 Earnings & Sales, Ups 2018 View
by Zacks Equity Research
Boston Beer (SAM) tops earnings and sales estimates for third-quarter 2018, backed by solid depletion growth and robust shipment volume.
Boston Beer (SAM) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Boston Beer (SAM) delivered earnings and revenue surprises of 1.26% and 20.79%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Higher Costs Mar Boston Beer's (SAM) Earnings in Q3?
by Zacks Equity Research
Boston Beer's (SAM) three-point growth plan focused on cost-saving actions, long-term innovation, and revival of Samuel Adams and Angry Orchard brands bodes well despite high costs.
Boston Beer (SAM) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Boston Beer (SAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Reasons Why Boston Beer (SAM) Must Be in Your Portfolio
by Zacks Equity Research
Boston Beer (SAM) shows resilience, driven by progress on three-point growth plan, focused on cost-saving initiatives, long-term innovation, and revival of Samuel Adams and Angry Orchard brands.
Bear of the Day: Constellation Brands (STZ)
by Benjamin Rains
This alcoholic beverage giant is embarking on a new journey and its earnings revisions are trending in the wrong direction.
Can Molson Coors Survive on Strategies as Beer Loses Fizz?
by Zacks Equity Research
Molson Coors (TAP) looks attractive, based on its focus on cost savings and premiumization as well as exposure to the marijuana space. But, overall softness in the beer industry weighs on the stock.
SAM Vs. TAP: Which Stock is Better Placed as Beer Loses Fizz?
by Zacks Equity Research
Beer space suffers due to soft beer sales, thanks to consumers shift to healthier options. However, players with diversified portfolio stand to gain. Let's see which a better stock in this space is.
Know How Beverage Stocks Will Gain From Shift to Marijuana
by Rajani Lohia
Cannabis-infused drinks have emerged as an attractive alternative to the problems of the players in the U.S. beverage space, given the health benefits it offers.
Boston Beer (SAM) Surges Despite Beer Woes: Will it Persist?
by Zacks Equity Research
Boston Beer (SAM) rallies despite industry headwinds, including a soft beer category, a shift to healthier drinks and higher costs. The company's non-beer portfolio shows potential for further growth.
Brown-Forman (BF.B) Tops Q1 Earnings & Sales, Trims View
by Zacks Equity Research
Brown-Forman (BF.B) tops earnings and sales estimates in first-quarter fiscal 2019. It continues to gain from broad-based growth across geographies and a balanced portfolio contribution.
Archer Daniels (ADM) Up 26% YTD: Will the Momentum Continue?
by Zacks Equity Research
Archer Daniels (ADM) looks promising backed by cost-savings efforts and management of its business portfolio. The company has an impressive earnings surprise trend as well.
Coca-Cola's (KO) Investment in BODYARMOR to Augment Sales
by Zacks Equity Research
Coca-Cola (KO) plans to acquire a minority ownership stake in BODYARMOR, which is likely to boost the company's top line and overall profitability.
Monster Beverage (MNST) Q2 Earnings Top, Sales Lag Estimates
by Zacks Equity Research
Monster Beverage (MNST) reports mixed second-quarter 2018 results. Further, management is on track with the launch of Monster Energy brand which is likely to boost sales.
Keurig Dr Pepper (KDP) Reports KGM & DPS Q2 Earnings & Sales
by Zacks Equity Research
Keurig Dr Pepper (KDP) reports individual second-quarter 2018 results for Dr Pepper Snapple and Keurig Green Mountain. The company will report the combined results from third-quarter 2018.
Energizer Holdings (ENR) Q3 Earnings Meet Estimates, Rise Y/Y
by Zacks Equity Research
Energizer (ENR) posts robust third-quarter fiscal 2018 results on strong organic net sales and gross margin expansion.
Church & Dwight (CHD) Updates View on Robust Q2 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) top and bottom lines increase year over year and surpass the Zacks Consensus Estimate in Q2.
Avon (AVP) Reports Loss in Q2, Revenues Fall Shy of Estimates
by Zacks Equity Research
Avon (AVP) reports dismal second-quarter 2018 results as both top and bottom lines lag estimates. Additionally, the company's margins remain soft.
Can Beer & Soda Makers Survive Trump Tariffs With Price Hike?
by Ritujay Ghosh
Higher tariffs on aluminum have started pinching the profits of beer and soft beverage manufacturers. Understandably, the higher prices are now being passed on to consumers.
Molson Coors (TAP) Stock Declines Despite Q2 Earnings Beat
by Zacks Equity Research
Molson Coors (TAP) beats earnings and sales estimates for second-quarter 2018 due to favorable global net pricing, realized cost savings, lower marketing spend and a lower tax rate.
Archer Daniels' (ADM) Stock Up on Q2 Earnings & Sales Beat
by Zacks Equity Research
Archer Daniels' (ADM) better-than-expected second-quarter results can be attributed to the company's strategic growth initiatives and robust cost-saving efforts.
P&G (PG) Beats on Q4 Earnings, Stock Falls on Revenue Miss
by Zacks Equity Research
Procter & Gamble (PG) reports better-than-expected earnings for fourth-quarter fiscal 2018 but misses sales estimates. Further, the company's fiscal 2019 guidance disappoints.
Market News For Jul 30, 2018
by Zacks Equity Research
Companies in the news are: CL, SBUX, SAM and EXPE
Colgate's (CL) Q2 Earnings In Line With Estimates, Sales Lag
by Zacks Equity Research
Colgate (CL) delivers first-quarter 2018 earnings in line with the Zacks Consensus Estimate but its sales lag. However, both the top and bottom line improves year over year.